$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Hematology
Hematology
普纳替尼治疗白血病效果好吗?
2025-10-19 11:44:20
Check Details
普纳替尼是什么时候上市的?
2025-10-19 11:44:20
Check Details
普纳替尼简介
2025-10-19 11:44:20
Check Details
普纳替尼用于治疗慢性髓性白血病
2025-10-19 11:44:20
Check Details
普纳替尼治疗罕见白血病
2025-10-19 11:44:20
Check Details
普纳替尼是一种什么药物?
2025-10-19 11:44:20
Check Details
普纳替尼在大陆一盒多少钱?
2025-10-19 11:44:20
Check Details
Ponatinib能否作为慢粒白血病患者使用的药物
2025-10-19 11:44:20
Check Details
普纳替尼一个月消费多少?
2025-10-19 11:44:20
Check Details
Ponatinib治疗白血病
2025-10-19 11:44:20
Check Details
Ponatinib治疗白血病的疗效
2025-10-19 11:44:20
Check Details
普纳替尼有几个版本?
2025-10-19 11:44:20
Check Details
1
2
...
152
153
154
155
156
157
158
...
938
939
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Belumosudil for cGVHD: 200mg with Food, Pregnancy Contraception, Liver Monitoring, Drug Interactions
2
Acalabrutinib in CLL/SLL Survival Expectation: ELEVATE-TN and ASCEND Long-Term PFS, OS
3
Bosutinib for CML: Time to Response, BCR-ABL Monitoring, and Molecular Remission
4
Acalabrutinib Dosing and Combination Regimens: CLL/SLL, MCL, Safety Adjustments
5
Bosutinib for Ph+ CML: Indications, Dosing Adjustments, and Hepatic/Renal Safety
6
AZA+VEN+IVO Triplet Therapy for Newly Diagnosed IDH1 AML: High Response Rates and Durable Efficacy
7
Anagrelide and Myelofibrosis Risk: Controversy and Monitoring in ET Treatment
8
Acalabrutinib Dosing Guide: Dosage, Duration and Precautions
9
Enasidenib: A Targeted IDH2 Inhibitor for Acute Myeloid Leukemia
10
Ponatinib in Chronic Myeloid Leukemia: 5-Year Results from the OPTIC Trial
11
Midostaurin (Rydapt): Dosing Essentials in FLT3-Mutated AML and Systemic Mastocytosis
12
Bosutinib Indications Explained: CML Targeted Therapy and ADPKD Research Insights